Global TB Program

Small acts of kindness can inspire hope for those facing TB. Let's offer support and compassion to patients, caregivers, and healthcare providers. Together, we can positively affect their path to health. 💙 #TB #KindnessMatters

Today is International Childhood Cancer Day! Did you know that #TB is a common co-infection in children with cancer? It's crucial to raise awareness and support research efforts to improve diagnosis and treatment for these vulnerable patients. #ICCD2026

Today, we celebrate the International Day of Women and Girls in Science and recognize the invaluable contributions of the women on our team! #WomenInScience #IDWGS

Join us on National #WearRedDay to raise awareness about #HeartDisease. Taking care of your health helps prevent heart disease and reduce TB risk. Stay active, eat heart-healthy foods, and get regular check-ups to keep both at bay! #HeartHealth #TBawareness

👏Publication Alert👏
TB mainly appears as pulmonary TB, but extrapulmonary TB is a significant challenge due to diagnostic and therapeutic difficulties. Differences in immune responses, pathogen behavior, and host susceptibility are key factors. buff.ly/ElpMK45
Congrats to all contributors👏

#GlobalCommunityEngagementDay highlights the importance of collaboration in addressing global health challenges like #TB. Community engagement is crucial for raising awareness, improving care access, and reducing TB stigma. Let's unite diverse communities to work towards a TB-free world. #GlobalTB

TB not only impacts health but also education for millions of children globally. On #InternationalDayOfEducation, let's emphasize the importance of education in preventing TB. Accessible healthcare and support are crucial to ensure every child's right to both health and education. #EndTB

Dr. Martin Luther King Jr. championed health equity as a core human right. Let's honor his legacy in advocating for #TB eradication and equal healthcare access, reflecting his dream of fairness in health. #HealthJustice

Non-invasive diagnosis of pulmonary tuberculosis using face mask sampling: A prospective study in adults - PubMed These findings highlight the potential additive yield and complementary role of FMS. Where resources allow, FMS may serve as a valuable diagnostic tool used in parallel to conventional diagnostics to…

🚨Publication Alert🚨

FMS for TB diagnosis
✅ Non-invasive alternative to sputum tests
📊 Sensitivity: 64.4% vs. culture; 58.3% vs. Xpert
🔍 Adds value—detected TB in cases missed by Xpert
FMS could complement conventional methods to speed TB detection

buff.ly/wUSF50f

Congrats to all contributors 👏

Reflecting on a year of progress in the #GTB Program. Together, we've strengthened prevention efforts, expanded access to treatment, and improved care for those affected by #TB. Here's to keeping up the momentum in 2026! #globalhealth #EndTB

HIV-associated drug-resistant TB: expanded treatment options and emerging threats - PubMed Treatment options for DR-TB have improved dramatically with less toxic, more effective regimens, but managing HIV-associated DR-TB continues to require careful attention to drug-drug interactions and…

🚨Publication Alert🚨
New review highlights major advances in DR‑TB treatment for PLWH — from shorter all‑oral regimens to promising investigational drugs + host‑directed therapies. Still critical: managing drug‑drug interactions + rising resistance.
buff.ly/VbAoNrS
Congrats to all contributors👏

Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesity - PubMed This trial was retrospectively registered at ClinicalTrials.gov Identifier NCT07120035 on August 12, 2025. The trial protocol and statistical analysis plan can be accessed by contacting the…

🚨Publication Alert🚨
This study explores the impact of carotenoids on inflammation in obese individuals. While carotenoids have anti-inflammatory properties, their short-term effects on obesity-related inflammation are unclear. buff.ly/IycidLl
Congrats to all contributors👏

Wishing everyone a joyous holiday season filled with love, laughter, and cherished moments. May this festive season bring you peace, and may the spirit of giving and gratitude shine bright in your hearts. 🎄✨ #HappyHolidays

An assessment of video-observed treatment as an adherence support tool for patients with drug-resistant TB In 2017, WHO endorsed digital adherence technologies, including video-observed treatment (VOT), to support TB treatment adherence. In 2021, Eswatini implemented VOT to support adherence for…

🚨 Publication Alert🚨
WHO has endorsed tools like VOT for TB. Eswatini implemented VOT for #DRTB patients, despite limited evidence of feasibility in low-resource environments. VOT is feasible and acceptable in Eswatini, but more research is needed. buff.ly/vYti3vZ
Congrats to all contributors👏

Today, on #HumanRightsDay, let us remember that access to healthcare, including #TB prevention and treatment, is a fundamental human right. Join us in raising awareness, advocating for equitable healthcare systems, and ensuring no one is left behind in the fight against TB. #OurEverydayEssentials

Honoring #IndependenceDay with heartfelt thanks to our partners and allies dedicated to tackling #TB in #Tanzania! Together, we strive for healthier futures and true freedom. Did you know TB is still a major global health challenge? Let's make a difference! #EndTB #TBSky

Today we support non-profit and NGO organizations fighting #TB. Join the global movement of generosity this #GivingTuesday by supporting these organizations! Your donation can make a difference in the lives of those affected by this disease. #EndTB #HealthForAll

Efficacy of a Mobile Serious Game (SwaziYolo) for Increasing HIV Risk Perception: Randomized Controlled Trial - PubMed UMIN Clinical Trial Registry UMIN000021781; https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025103.

🚨Publication Alert🚨
Eswatini's high HIV prevalence is driven by unprotected heterosexual transmission and low risk awareness. SwaziYolo, a smartphone game, aims to boost HIV risk perception and prevention intentions among Eswatini's youth. buff.ly/6XXSNIZ
Congrats to all contributors👏

Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the…

🚨Publication Alert🚨
Tackling the issue of identifying drug resistance in paucibacillary TB patients, targeted stool sequencing provides patient confirmation and detailed resistance data. Read more: buff.ly/lizXBFt
Congrats to all contributors👏

As we gather with loved ones to give thanks, let this holiday be a reminder of the importance of kindness, love, and generosity towards others. #Thanksgiving #Gratitude #GivingBack

Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska | Microbiology Spectrum Globally, tuberculosis is the leading infectious cause of mortality with 10.8 million new cases and 1.25 million deaths occurring in 2024. Targeted next-generation sequencing (tNGS) is a rapid,…

🚨Publication Alert🚨
Alaska has the highest incidence of TB in the US, with 8% mortality while undergoing treatment. Given that 1/4 of cases lack sputum culture for DR testing, FreezeTB aimed to develop tools tailored to these challenges.
buff.ly/gsD1rvY
Congrats to all contributors👏

🎯 Final day of #UnionConf2025!
As we wrap up a week of science, advocacy, and collaboration, we are proud to support colleagues presenting research and innovations. Their work is advancing progress toward ending TB — and collective attention helps ensure these insights reach the world.
#TBSky

🤝 Day 3 of the Union Conference and we're highlighting collaboration and community with our partners. Global TB progress depends on partnerships — between researchers, health workers, policymakers, and affected communities.

#UnionConf2025 #CommunityHealth #GlobalTB #TBSky

🔬 Day 2 at #UnionConf2025!
Today’s sessions highlight cutting-edge TB science—from implementation to economic tools. Your engagement helps bring attention to the innovations driving impact!
#TBScience #Innovation #EndTB #TBSky

🌍Day 1 of #UnionConf2025!
The global TB community is gathering to share groundbreaking research, innovative tools, and lessons from the field. Let’s show our support for colleagues presenting on TB prevention, treatment, and care worldwide. #TBSky #GlobalHealth #TBResearch

📢 Attention #GTB colleagues! Join us for #UnionConf2025 to explore #TB and #GlobalHealth innovations. Experience the power of collaboration to #EndTB through exclusive insights and discussions. Don't miss this chance to make a real impact in the fight against TB—mark your calendars! #TBSky

Did you know that people with #diabetes are at a higher risk of developing #TB? Today, let's raise awareness about the importance of access to diabetes care and how it can also impact #TBprevention. #WorldDiabetesDay #AccessToCare

Estimating the Accuracy and Additionality of TB-LAM to Diagnose TB in Children Without HIV (AccuLAM) - PubMed New diagnostic tests and alternative samples to diagnose tuberculosis in children are needed to tackle the diagnostic gap of pediatric tuberculosis. The Determine TB LAM Ag test in urine demonstrated…

🚨 Publication Alert🚨
New pediatric TB diagnostic tools are urgently needed. The Determine TB LAM Ag urine test has 15.9% sensitivity and 90.6% specificity. Using an adhesive urine collection bag increases positivity risk.
buff.ly/BVNPbqm
Congrats to all contributors👏
#PediatricTB #HealthInnovation

Congratulations to Dr. Phumzile Dlamini on earning her PhD in Nursing from the University of South Africa. Her dedication to academic excellence and pioneering research is commendable. Best wishes for her continued success! #NursingLeadership #PhDAchievement #GlobalTB

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children - PubMed The protocol for this review was originally published through Cochrane in 2019. The protocol for this update was a generic protocol that consolidated previously published Cochrane protocols of Xpert…

🚨Publication Alert🚨
In 2023, 1.3 million children developed TB. Xpert Ultra was reviewed for diagnostic accuracy in children for TB and rifampicin resistance, showing moderate sensitivity and high specificity.
buff.ly/JESD2q2
Congrats to all contributors👏